Redhill Biopharma Ltd. - American Depositary Shares (RDHL)
0.9786
+0.0786 (8.73%)
NASDAQ· Last Trade: Sep 1st, 5:44 AM EDT
Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 69.4% to $1.12 during Monday's regular session. The company's market cap stands at $4.0 million. CollPlant Biotechnologies (NASDAQ:CLGN) shares
Via Benzinga · August 31, 2026
Gainers Redhill Biopharma (NASDAQ:RDHL) shares increased by 96.7% to $1.3 during Monday's pre-market session. The market value of their outstanding shares is at $4.0 million. Vivos Therapeutics (NASDAQ:VVOS) stock
Via Benzinga · August 31, 2026
Get insights into the top gainers and losers of Friday's after-hours session.chartmill.com
Via Chartmill · June 12, 2026
Wondering what's happening in today's pre-market session?chartmill.com
Via Chartmill · January 5, 2026
RedHill Biopharma Logs Best Session In Over A Year After $10M Legal Victory — Retail Sees Bullish Triggers Aheadstocktwits.com
Via Stocktwits · September 29, 2025
Via Benzinga · November 5, 2025
Via Benzinga · October 22, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · September 29, 2025
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.
Via Benzinga · September 29, 2025
Via Benzinga · August 13, 2025
The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · July 21, 2025
Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · July 21, 2025
Via Benzinga · July 18, 2025
Via Benzinga · July 18, 2025
Via Benzinga · July 17, 2025
Via Benzinga · April 21, 2025
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Via Chartmill · April 17, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · April 16, 2025
Via Benzinga · April 16, 2025

Via Benzinga · February 13, 2025

New Prostate Cancer Hope? Bayer-Funded Phase 2 Study To Test Combination Of RedHill's Opaganib And Bayer’s Darolutamide, To Overcome Androgen Resistance
Via News Direct · February 5, 2025

Via Benzinga · January 21, 2025